Skye Bioscience Profit Margin

Skye Bioscience (SKYE) currently reports a profit margin of -Infinity% as of March 2026. That is below the sector sector average of 19.72%. Use the charts on this page to explore Skye Bioscience's profit margin history and peer comparisons.

Skye Bioscience's profit margin of -Infinity% is lower than the its sector sector average of 19.72%. That is roughly Infinity% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Skye Bioscience's current -Infinity% should be judged against industry norms (sector average: 19.72%) and against SKYE's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -Infinity%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 19.72%. From there, open related valuation or income-statement pages for Skye Bioscience, and consider following SKYE for alerts when major investors trade the stock.